Profling of matrix metalloproteinases and tissue inhibitors of metalloproteinases proteins in bladder urothelial carcinoma

Oncology Letters

Volumn 1, Issue 4, 2010, Pages 691-695

  Chuang, Cheng Keng ^a   Pang, See Tong ^a   Chuang, Tai Jung ^a   Liao, Shuen Kuei ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Bladder neoplasm; Cell line; Matrix metalloproteinases; Metastasis; Tissue inhibitors of metalloproteinases

Indexed keywords

CYTOKINE; GELATINASE A; GELATINASE B; GROWTH FACTOR; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 9A; MATRIX METALLOPROTEINASE 9B; MONOCLONAL ANTIBODY; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CARCINOMA; BLADDER UROTHELIAL CARCINOMA; CANCER CELL CULTURE; CANCER INVASION; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; PROGNOSIS; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; ZYMOGRAPHY;

EID: 77954903679     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol_00000121     Document Type: Article

References (33)

1. Liotta LA: Tumor invasion and metastasis: role of the extracellular matrix. Cancer Res 46: 1-7, 1986.
2. Chuang CK and Liao SK: Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinoma. Anticancer Res 23: 4635-4640, 2003.
3. Brown PD, Levy AT, Margulies IMK, Liotta LA and Stetler-Stevenson WG: Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50: 6184-6191, 1990.
4. Fleshner NE, Herr HW, Stewart AK, Murphy GP, Mettline C and Menck HR: The national cancer data base report on bladder carcinoma. Cancer 77: 1505-1513, 1996.
5. Chuang CK and Liao SK: Evaluation of CA19-9 as a tumor marker in urothelial malignancy. Scand J Urol Nephrol 38: 359-365, 2004.
6. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM and Shafe S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68, 1980.
7. Koivunen E, Ristimaki A, Itkonen O, Osman S, Vuento M and Stenman UH: Tumor-associated trypsin participates in cancer cell mediated defradation of extracellular matrix. Cancer Res 51: 2107-2112, 1991.
8. Van Wart HE and Birkedal-Hansen H: The cysteine switch: 21. a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87: 5578-5582, 1990.
9. Mignatti P and Rifkin DB: Biology and biochemistry of protei-nases in tumor invasion. Physiol Rev 73: 161-195, 1993.
10. Liu BCS and Liotta LA: Biochemistry of bladder cancer invasion 23. and metastasis: clinical implications. Urol Clin North Am 19: 621-627, 1992.
11. Redwood SM, Liu BCS, Weiss RE, Hodge DE and Droller MJ: 24. Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s). Cancer 69: 1212-1219, 1992.
12. Liotta LA and Stetler-Stevenson WG: Tumor invasion and 25. metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054-5059, 1991.
13. Agnes N, Maud J and Erik M: Matrix metalloproteinases at 26. cancer tumor-host interface. Semin Cell Dev Biol 19: 52-60, 2008.
14. Kitagawa Y, Kunimi K, Ito H, et al: Expression and tissue local- 27. ization of membrane-types 1, 2 and 3 matrix metalloproteinases in human urothelial carcinomas. J Urol 160: 1540-1545, 1998.
15. Nakajima M, Welch DR, Belloni PN and Nicolson GL: Degradation and basement membrane type IV collagen and lung subendotherial matrix by rat mammary adenocarcinoma 28. cell clones of differing metastatic potentials. Cancer Res 47: 4869-4876, 1987.
16. Nakajima M, Welch DR, Wynn DM, Tsuruo T and Nicolson GL: Serum and plasma Mr 92,000 progelatinase levels correlate with 29. spontaneous metastasis of rat 13762NF mammary adenocarci-noma. Cancer Res 53: 5802-5807, 1993.
17. Pyke C, Ralfkiaer E, Tryggvason K and Dano K: Messenger RNA for two type IV collagenases is located in stromal cells in 30. human colon cancer. Am J Pathol 142: 359-365, 1993.
18. Stearns ME and Wang M: Type IV collagenase (Mr 72,000) expression in human prostate: benign and malignant tissue. Cancer Res 53: 878-883, 1993.
19. Kanayama HO, Yokota KY, Kurokawa Y, Murakami Y, Nishitani M and Kagawa S: Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer 82: 1359-1366, 1998.
20. Grignon DJ, Sakr W, Toth M, et al: High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res 56: 1654-1659, 1996.
21. Hanahan D and Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996.
22. Davis B, Waxman J, Wasan H, et al: Levels of matrix metal-loproteinase in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 5365-5369, 1993.
23. Gerhards S, Jung K, Koenig F, et al: Excretion of matrix metal-loproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma. Urology 57: 675-679, 2001.
24. Cawston TE, Galloway WA, Mercer E, Murphy G and Reynolds JJ: Purifcation of rabbit bone inhibitor for collagenase. Biochem J 195: 159-165, 1981.
25. Docherty AJ, Lyons A, Smith BJ, et al: Sequence of human tissue inhibitor of metalloproteinases and its identity to eryth-roid-potentiating activity. Nature 318: 66-69, 1985.
26. Mignatti P, Robbins E and Rifkin DB: Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47: 487-498, 1986.
27. Schultz RM, Silberman S, Persky B, Bajkowski AS and Carmichael DF: Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 48: 5539-5545, 1988.
28. Alvarez OA, Carmichael DF and DeClerck YA: Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhititor of metalloproteinases. J Natl Cancer Inst 82: 589-595, 1990.
29. Stetler-Stevenson WG, Krutzsch HC and Liotta LA: TIMP2: identifcation and characterization of a new member of the metalloproteinases inhibitor family. Matrix Supplement 1: 299-306, 1992.
30. Denhardt DT, Khokha R, Yagel S, Overall CM and Parhar RS: Oncogenic consequences of down-regulating TIMP expression in 3T3 cells with antisense RNA. Matrix Supplement 1: 281-285, 1992.
31. Baker EA, Stephenson TJ, Reed MW and Brown NJ: Expression of proteinases and inhibitors in human breast cancer progression and survival. Mol Pathol 55: 300-304, 2002.
32. Takahashi K, Eto H and Tanabe KK: Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells. Int J Cancer 29: 387-395, 1999.
33. Isacke CM and Yarwood H: Molecules in focus. The hyaluronan receptor, CD44. Int J Biochem B 34: 718-721, 2002.